Tirzepatide 10mg is a dual GIP and GLP-1 receptor agonist that has shown significant potential in metabolic research. This synthetic peptide demonstrates glucose-dependent insulin secretion while reducing glucagon secretion, making it valuable for diabetes and obesity-related studies.
The 10mg formulation comes as a white lyophilized powder with ≥99% purity, ensuring consistent research results. As a novel peptide therapy, tirzepatide 10mg offers researchers opportunities to explore its mechanisms in glucose regulation and weight management.
For optimal stability, tirzepatide 10mg should be stored in a cool, dry environment protected from light. Researchers should avoid repeated freeze-thaw cycles and minimize exposure to air when reconstituting the peptide.
This product is supplied for laboratory research purposes only. Not for human consumption or diagnostic use. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.